NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

TTK HEALTHCARE LTD.

NSE : TTKHLTCAREBSE : 507747ISIN CODE : INE910C01018Industry : Pharmaceuticals & DrugsHouse : TTK
BSE1635.2043.85 (+2.76 %)
PREV CLOSE ( ) 1591.35
OPEN PRICE ( ) 1590.90
BID PRICE (QTY) 1627.85 (1)
OFFER PRICE (QTY) 1635.25 (5)
VOLUME 259
TODAY'S LOW / HIGH ( )1590.90 1635.20
52 WK LOW / HIGH ( )1117.05 1725.85
NSE1630.0024.6 (+1.53 %)
PREV CLOSE( ) 1605.40
OPEN PRICE ( ) 1582.05
BID PRICE (QTY) 1628.75 (1)
OFFER PRICE (QTY) 1632.55 (1)
VOLUME 15281
TODAY'S LOW / HIGH( ) 1582.05 1640.00
52 WK LOW / HIGH ( )1101.2 1744
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1958
Management Info
T T Raghunathan - Chairman - Managing Director
Registered Office

Address No 6 , Cathedral Road, , ,
Chennai,
Tamil Nadu-600086

Phone 044-28116106-08

Email info@ttkhealthcare.com

Website www.ttkhealthcare.com

Registrars Details
Data Software Research Co Pvt Ltd
19 Pycroft Garden Road,Off Haddows Road,Nungambakkam,Chennai
 Listing : BSE, NSE, MCX
NEWS
22Dec Ttk Healthcare informs about clarifica
With acknowledge receipt of communication L/SURV/ONL/PV/NP/2023-2024/497..
21Nov Ttk Healthcare informs about loss of s
Ttk Healthcare has informed that it enclosed Certificate under Reg 39(3)..
03Nov Ttk Healthcare submits unaudited finan
Ttk Healthcare has informed that it enclosed the Unaudited Financial Res..
17Aug TTK Healthcare informs about details o
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, TTK Healt..
26May TTK Healthcare informs about secretari
In accordance with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8th Febr..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit128.956397.15
Gross Profit 177 616.370000000001
Operating Profit 212.4796.820000000001
Net Sales 1838.477251.1
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1671.00 (8.01%)
M.Cap (Rs. in Cr)987.22
NGL Fine-Chem (BSE)
 2744.60 (4.72%)
M.Cap (Rs. in Cr)1695.74
Alkem Laboratories (BSE)
 4809.10 (2.06%)
M.Cap (Rs. in Cr)57378.65
Dr. Reddy's Lab (BSE)
 6019.60 (1.15%)
M.Cap (Rs. in Cr)99970.85
Vimta Labs (BSE)
 573.30 (12.53%)
M.Cap (Rs. in Cr)1275.92
MORE
Shareholding Pattern
PROMOTERS 74.56%
NON-INSTITUTION 22.45%
FII 1.85%
FI/BANKS/INSURANCE 0.01%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
MORE
Mf Holdings
Scheme NameHold(%)
No Data Found
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.